Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Epodion in Hemodialysis Patients with CKD Anemia
NCT05373303Completed
- Sponsor
- Daewoong Infion
- Start
- Nov 2019
- Primary completion
- May 2021
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
Randomised, open-label trial of Epodion in anemia of chronic kidney disease (CKD-A) (2 arms), sponsored by Daewoong Infion. Primary endpoint: Hemoglobin level change. Started Nov 2019; status: completed.
02
Drugs
Epodion
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT05373303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05373303.